by admin | Aug 3, 2022 | Uncategorized
SOFAR is an Italian company specializing in pharmaceutical products, food supplements and medical devices Alfasigma consolidates its leadership in the gastrointestinal area and the research focus on the microbiota The acquisition is expected to be completed in October...
by admin | Apr 29, 2022 | Events
Dear NEUROdiab Members and Friends, It is a great pleasure to announce that the 32nd Annual Meeting of NEUROdiab is now on the web (https://www.NEUROdiab.eu/annual-meeting-2022) (https://www.delegia.com/app/netattm/attendee/page/108782) and that the abstract...
by admin | Jan 28, 2022 | Pharma
Aim: To assess whether small and large fibre damage due to diabetic sensorimotor polyneuropathy (DSPN) in type 1 (T1D) and type 2 diabetes (T2D) could develop in parallel and whether it may be reversible. Methods: Prospective observational study of subjects from...
by admin | Apr 14, 2021 | Pharma
Interview with Sévan Kaloustian Managing Director Janssen, Administrator Johnson & Johnson Romania Johnson& Johnson has a long standing history. What is the company’s commitment? The company’s long standing history is more of a heritage, as well as a living...
by admin | Feb 12, 2021 | Prevention
Professor Cynthia Formosa Professor Cynthia Formosa PhD FFPM RCPS (Glasg.)Head/Associate ProfessorPodiatry DepartmentFaculty of Health SciencesUniversity of Malta What is the latest news in podiatry? It has been a very difficult time. People neglected their...
